STAT+: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal

German drugmaker MorphoSys said Wednesday that it will acquire Constellation Pharmaceuticals for $1.7 billion to bolster its research pipeline of cancer drug candidates.

Constellation, based in Cambridge, Mass. is in the late stage of clinical trials for a drug to treat patients with myelofibrosis, a type of bone marrow cancer. The company is also developing a second drug in earlier development for different types of blood-related cancers and solid tumors.

Continue to STAT+ to read the full story…

STAT+: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top